Human Technology Q1 Performance Deteriorates: Revenue Plunges, Operating Loss Widens


  • Q1 consolidated revenue KRW 9.16bn (down 27.8% YoY), operating loss KRW 2.96bn (vs loss KRW 1.99bn YoY), net loss KRW 3.75bn (vs loss KRW 1.69bn YoY)
  • Continued losses: retained deficit -KRW 84.1bn, debt ratio 42.54% (improved from 50.13% at year-end but accumulated deficit deepens)
  • EPS loss -KRW 150 (vs -KRW 76 YoY); trade receivables allowance rate 50.15%; royalty provision KRW 1.03bn
  • High customer concentration: Top customer A accounted for 58% of sales; credit rating maintained at B- (Ecredible)
  • Disposal of subsidiary CarboX shares; planned merger with Humans Agos (June 30, 2026) — restructuring with unclear short-term improvement
  • No share buyback, cancellation, or dividend announcements

KOSDAQ Filing Information


  • Filing: Quarterly Report (2026.03)
  • Company: Human Technology (175140)
  • Submission: Human Technology Co., Ltd
  • Receipt: 05-15-2026